date,title,source
Oct-22-18,ESMO 2018: Athenex Presented Encouraging Clinical Trial Efficacy and Safety Results of Oraxol in the Treatment of Metastatic Breast Cancer,GlobeNewswire
Oct-26-18,"Recent Analysis Shows Prologis, Delek Logistics Partners, Fabrinet, New York Mortgage Trust, Petroleo Brasileiro S.A.- Petrobras, and Athenex Market Influences  Renewed Outlook, Key Drivers of Growth",GlobeNewswire
Oct-29-18,Athenex Announces FDA Allowance of Investigational New Drug Application of Eribulin ORA to Begin Clinical Trials,GlobeNewswire
Nov-01-18,"Athenex, Inc. to Report Third Quarter Earnings Results on November 14, 2018",GlobeNewswire
Nov-14-18,"Athenex Inc (ATNX) CEO and Chairman of the Board Johnson Yiu Nam Lau Bought $418,800 of Shares",GuruFocus.com
Nov-14-18,Edited Transcript of ATNX earnings conference call or presentation 14-Nov-18 1:00pm GMT,Thomson Reuters StreetEvents
Nov-14-18,Athenex: 3Q Earnings Snapshot,Associated Press
Nov-14-18,"Athenex, Inc. Announces Third Quarter 2018 Financial Results and Provides Corporate Update",GlobeNewswire
Nov-19-18,"Athenex Inc (ATNX) CEO and Chairman of the Board Johnson Yiu Nam Lau Bought $117,500 of Shares",GuruFocus.com
Nov-26-18,Athenex Announces Initiation of a Phase I/II Clinical Study of Oraxol in Combination with Anti-PD1,GlobeNewswire
Nov-29-18,Athenex Announces Licensing Agreement with PharmaEssentia for Rights to Oradoxel (Oral Docetaxel) in Certain Asian Territories,GlobeNewswire
Dec-06-18,"Recent Analysis Shows Athenex, National CineMedia, Macy's, Manulife Financial, CBS, and Strategic Education Market Influences  Renewed Outlook, Key Drivers of Growth",GlobeNewswire
Dec-06-18,Athenex to Host an R&D Day on December 17 in New York,GlobeNewswire
Dec-11-18,CORRECTION: Athenex Announces Positive Second Cohort Results of Oraxol-plus-Ramucirumab Phase 1b Clinical Trial in Gastric Cancer,GlobeNewswire
Dec-11-18,Athenex Announces Positive Second Cohort Results of Oraxol-plus-Ramucirumab Phase 1b Clinical Trial in Gastric Cancer,GlobeNewswire
Dec-13-18,"Company News For Dec 13, 2018",Zacks
Dec-20-18,"What Kind Of Shareholders Own Athenex, Inc. (NASDAQ:ATNX)?",Simply Wall St.
Dec-26-18,"Athenex Pharmaceutical Division, an Athenex, Inc. Company, Launches Levothyroxine Sodium for Injection",GlobeNewswire
Jan-03-19,Chongqing Jingdong Pharmaceutical and Athenex Announce a Strategic Partnership and Licensing Agreement to Develop and Commercialize KX2-391 in China,GlobeNewswire
Jan-04-19,Teresa Bair talks about the big year ahead for Athenex,American City Business Journals
Jan-09-19,Athenex Announces Completion of Target Enrollment in the Oraxol Phase III Study,GlobeNewswire
Jan-10-19,Athenex Completes Enrollment Target for Breast Cancer Study,Zacks
Jan-10-19,Buffalo startups surpassed $200 million in VC and angel funding in 2018,American City Business Journals
Jan-16-19,Kitov Pharma's Stock Up on Anti-Cancer Candidate Findings,Zacks
Feb-04-19,Athenex Announces Late-Breaking Oral Presentation of KX2-391 Ointment in Two Phase III Studies at the American Academy of Dermatology Annual Meeting,GlobeNewswire
Feb-14-19,"Athenex, Inc. to Report Fourth Quarter and Fiscal Year 2018 Earnings Results on March 11, 2019",GlobeNewswire
Feb-25-19,"New Research Coverage Highlights The Wendy's, Rite Aid, Invesco, LendingClub, Diodes, and Athenex  Consolidated Revenues, Company Growth, and Expectations for 2019",GlobeNewswire
Feb-25-19,Athenex to Host Conference Call with Key Opinion Leader Following Oral Presentation of Phase III Results of KX2-391 Ointment in the Treatment of Actinic Keratosis at the American Academy of Dermatology Annual Meeting,GlobeNewswire
